Stock Warrants (Narrative) (Details) - $ / shares  | 
6 Months Ended | |
|---|---|---|
Jun. 30, 2015  | 
Mar. 11, 2015  | 
|
| Class of Warrant or Right [Line Items] | ||
| Warrants outstanding (shares) | 1,800,000 | |
| Common Stock | ||
| Class of Warrant or Right [Line Items] | ||
| Exercise price of warrant issued, dollars per share | $ 2,000 | |
| Common Stock | Macrophage Therapeutics | ||
| Class of Warrant or Right [Line Items] | ||
| Number of shares underlying warrant issued | 300 | 300 | 
| Minimum | ||
| Class of Warrant or Right [Line Items] | ||
| Exercise price of warrant issued, dollars per share | $ 1.918 | |
| Warrant, Outstanding Term | ||
| Maximum | ||
| Class of Warrant or Right [Line Items] | ||
| Exercise price of warrant issued, dollars per share | $ 3.04 | |
| Warrant, Outstanding Term | 8 years | |
| Weighted Average | ||
| Class of Warrant or Right [Line Items] | ||
| Exercise price of warrant issued, dollars per share | $ 2.27 | 
| X | ||||||||||
- Definition Class of Warrant or Right, Outstanding, Term No definition available. 
  | 
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/presentationRef 
  | 
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available. 
  | 
| X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/presentationRef 
  | 
| X | ||||||||||
- Definition Number of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/presentationRef 
  | 
| X | ||||||||||
- Details 
  | 
| X | ||||||||||
- Details 
  | 
| X | ||||||||||
- Details 
  | 
| X | ||||||||||
- Details 
  | 
| X | ||||||||||
- Details 
  |